As the Covid-19 pandemic enters its sixth month in India, Dr Randeep Guleria, Director of AIIMS, tells The Indian Express about key learnings from managing it, and new aspects that have emerged. Edited excerpts:
As the Covid-19 pandemic enters its sixth month in India, Dr Randeep Guleria, Director of AIIMS, tells The Indian Express about key learnings from managing it, and new aspects that have emerged. Edited excerpts: https://indianexpress.com/article/explained/dr-randeep-gulleria-coronavirus-covid-19-india-cases-6502680/
History shows us that there is no alternative to research in the battle against pandemics
https://www.outlookindia.com/magazine/story/india-news-why-does-science-come-last/303337
History shows us that there is no alternative to research in the battle against pandemics https://www.outlookindia.com/magazine/story/india-news-why-does-science-come-last/303337
Consolidated resource about ongoing COVID-19
https://clinicaltrials.gov/ct2/results/map/click?map.x=636&map.y=492&cond=COVID-19&map=SS&mapw=1259
Consolidated resource about ongoing COVID-19 https://clinicaltrials.gov/ct2/results/map/click?map.x=636&map.y=492&cond=COVID-19&map=SS&mapw=1259
Masks and testing are necessary to combat asymptomatic spread in aerosols and droplets
https://science.sciencemag.org/content/early/2020/05/27/science.abc6197
Masks and testing are necessary to combat asymptomatic spread in aerosols and droplets https://science.sciencemag.org/content/early/2020/05/27/science.abc6197
Summarizes recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008536
Summarizes recent progress in understanding the epidemiological, virological, and clinical characteristics of COVID-19 and discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008536
Live simulations that help you visualize multiple COVID-19 futures!
Live simulations that help you visualize multiple COVID-19 futures! https://ncase.me/covid-19/
https://ourworldindata.org/covid-cases
On 29 April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), announced that a clinical trial in more than 1,000 people had showed that those taking remdesivir recovered in 11 days on average, compared with 15 days for those on a placebo. There were also fewer deaths among trial participants who received the drug, he said, but that trend was not statistically significant. The shortened recovery time, however, was significant.
https://www.nature.com/articles/d41586-020-01295-8
Explains the emergence and spread of mutations in coronaviruses, and how this leads to disease, in a simple and clear manner
https://www.nytimes.com/interactive/2020/04/30/science/coronavirus-mutations.html
Explains the emergence and spread of mutations in Coronaviruses, and how this leads to disease, in a simple and clear manner
How to deal with different aspects of COVID-19 infection, detailed in different languages. Useful practical resource
https://www.noorahealthcovid19.org/
How to deal with different aspects of COVID-19 infection, detailed in different languages. Useful practical resource